相似文献
1
A dual-targeted lentiviral vector homing in on prostate bone metastases.
Mol Ther. 2007 Nov;15(11):1906-8. doi: 10.1038/sj.mt.6300317.
2
A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration.
Mol Ther. 2007 Nov;15(11):1973-81. doi: 10.1038/sj.mt.6300271. Epub 2007 Jul 24.
3
Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A.
Cancer Gene Ther. 2003 Oct;10(10):764-70. doi: 10.1038/sj.cgt.7700629.
4
Bioengineered viral vectors for targeting and killing prostate cancer cells.
Bioeng Bugs. 2010 Mar-Apr;1(2):92-6. doi: 10.4161/bbug.1.2.11102. Epub 2010 Jan 4.
5
New targets for therapy in prostate cancer: modulation of stromal-epithelial interactions.
Urology. 2003 Nov;62(5 Suppl 1):44-54. doi: 10.1016/s0090-4295(03)00796-9.
6
Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
Prostate. 2009 Sep 15;69(13):1422-34. doi: 10.1002/pros.20989.
7
Gene therapy for prostate cancer bone metastasis. Gene therapy targeting bone metastasis.
Cancer Treat Res. 2004;118:231-90. doi: 10.1007/978-1-4419-9129-4_11.
8
In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.
PLoS One. 2013;8(1):e53795. doi: 10.1371/journal.pone.0053795. Epub 2013 Jan 16.
9
Targeting L1 cell adhesion molecule expression using liposome-encapsulated siRNA suppresses prostate cancer bone metastasis and growth.
Oncotarget. 2014 Oct 30;5(20):9911-29. doi: 10.18632/oncotarget.2478.
10
Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
J Clin Oncol. 2005 Nov 10;23(32):8232-41. doi: 10.1200/JCO.2005.03.0841.
引用本文的文献
1
Comparison of prostate-specific promoters and the use of PSP-driven virotherapy for prostate cancer.
Biomed Res Int. 2013;2013:624632. doi: 10.1155/2013/624632. Epub 2013 Jan 31.
2
Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.
Cell Oncol (Dordr). 2013 Feb;36(1):15-26. doi: 10.1007/s13402-012-0107-3. Epub 2012 Oct 16.
本文引用的文献
1
A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration.
Mol Ther. 2007 Nov;15(11):1973-81. doi: 10.1038/sj.mt.6300271. Epub 2007 Jul 24.
2
Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.
Gene Ther. 2007 Jun;14(11):847-62. doi: 10.1038/sj.gt.3302947. Epub 2007 Mar 22.
3
Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Cardiovasc Res. 2006 Apr 1;70(1):70-8. doi: 10.1016/j.cardiores.2005.12.017. Epub 2006 Jan 31.
4
Targeting of therapeutic agents to bone to treat metastatic cancer.
Adv Drug Deliv Rev. 2005 May 25;57(7):995-1010. doi: 10.1016/j.addr.2004.12.014. Epub 2005 Apr 13.
5
Prostate stem cell antigen is overexpressed in prostate cancer metastases.
Clin Cancer Res. 2005 Apr 1;11(7):2591-6. doi: 10.1158/1078-0432.CCR-04-1842.
6
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection.
Nat Med. 2005 Mar;11(3):346-52. doi: 10.1038/nm1192. Epub 2005 Feb 13.
7
Osteoblasts in prostate cancer metastasis to bone.
Nat Rev Cancer. 2005 Jan;5(1):21-8. doi: 10.1038/nrc1528.
8
Progress and problems with the use of viral vectors for gene therapy.
Nat Rev Genet. 2003 May;4(5):346-58. doi: 10.1038/nrg1066.
9
No false start for novel pseudotyped vectors.
Curr Opin Biotechnol. 2002 Oct;13(5):437-42. doi: 10.1016/s0958-1669(02)00374-9.
10
Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors.
Hum Gene Ther. 2002 Jan 20;13(2):243-60. doi: 10.1089/10430340252769770.
Zotero 插件